AN1 11.1% 0.8¢ anagenics limited

Ann: Midkine Ischemia Patent Allowed in US , page-2

  1. Osi
    16,070 Posts.
    lightbulb Created with Sketch. 201
    To note ... I am VERY confident of the science here. The bottom line is the this treatment WILL IMO be used globally as emergency treatment for heart attack and stroke patients for year to come.

    Timeframe? Clinical trials with Pharmahungary next year .... mabe some commencing activity Q4 but I don't know this.

    Trial duration? It will be a lot shorter than a cancer trial becausue results will be obvious right away.

    Efficacy? has been demonstrated on small and large animals (pigs). Something like a 35%+ reduction in heart muscle damage for induced heart attacks in the swine. Human hearts will behave the same so this is HUGE. I dn't have the info on stroke but presumably data has gone to the US Patent Office to support the application.

    Alternatives: Not really. MK treatment can be used alongside other emergency treatment options. Paramedics and doctors will use all options in combination IMHO. Grantjo may like to add a more informed opinion here.

    Side Effects: I understand there are no side effects from ST midkine treatments.

    Its a big ticket item for Pharmahumgary IMHO. The US patent is a key groundwork requirement and will secure revenue for 20 years.


    I'm now waiting for news on other pipelines over the next little while to reinforce some excitement. Fingers crossed.

    cheers
 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
(20min delay)
Last
0.8¢
Change
-0.001(11.1%)
Mkt cap ! $3.691M
Open High Low Value Volume
0.8¢ 0.9¢ 0.8¢ $8.671K 1.051M

Buyers (Bids)

No. Vol. Price($)
2 1735002 0.8¢
 

Sellers (Offers)

Price($) Vol. No.
0.9¢ 340000 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.